Lungteh Shipbuilding Co., LTD
- Investment time: July, 2019 ~ June, 2022
- Investment cost: NT$ 42,429 thousand
- Amount recovered: NT$ 154,509 thousand
The company's main business is the production of medium and high-speed boats. Its uses include offshore patrol boats, inshore patrol boats, personnel operation and maintenance ships, high-speed passenger ships, research and survey ships, fire-fighting and rescue ships, port operation ships, and unmanned aerial vehicles. Boats, etc., and also provides repair services for ex-ships.
Tigerair Taiwan
- Investment time: Nov, 2020 ~ March, 2021
- Investment cost: $NT 30,000 thousand
- Amount recovered: $NT 41,760 thousand
Tigerair Taiwan officially launched on September 26th, 2014. It is an investment subsidiary of China Airlines Group, which also Taiwan's first and only low-cost airline in current. It will apply for listing at the end of December 2021. It hopes to assist Tigerair Taiwan through the listing capital increase plan. In the future, the aviation network will be deeply cultivated and expanded to achieve the goal of sustainable operation.
Drewloong Precision, INC.
- Investment time: July 17th, 2019 ~ June 4th, 2020
- Investment cost: $NT 65,676 thousand
- Amount recovered: $NT 97,281 thousand
Mainly engaged in the research, development, production and sales of large aircraft fuselage structural components, large aircraft engine structural components and special molds and jigs. In the international aerospace industry supply chain system, the company is a full-energy manufacturer of aircraft structures, has complete special process technology capabilities, and has certifications from major leading companies such as Boeing and Safran.
Locus Cell
- Investment time: April 27th, 2021 ~ April 1th, 2022
- Investment cost: $NT 50,000 thousand
- Amount recovered: $NT 99,700 thousand
Locus Cell is led by Hong-Nerng Ho, the former president of National Taiwan University Hospital, and cooperates with Dr. Kazuchika Furuishi, the former CEO of Japan's Hitachi Group and Minaris, the world's largest cell therapy CDMO in terms of market share, to introduce advanced foreign cell therapy products and technical resources, and Taiwan’s medical clinical resources to jointly create Asian’s largest cell therapy factory.
Enrestec
- Investment time: July 17th, 2019 ~ June 4th, 2020
- Investment cost: $NT 65676 thousand
- Amount recovered: $NT 97,281 thousand
Enrestec uses its original thermal cracking technology to effectively regenerate waste rubber products and resources into raw materials needed for the industry. At the same time, it provides innovative technologies for the rubber industry chain and fully utilizes low-carbon recycled raw materials in accordance with the circular economy production model to achieve low-carbon production. The goal is to reduce Taiwan’s demand for energy resources.
